Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.

van Vloten JP, Workenhe ST, Wootton SK, Mossman KL, Bridle BW.

J Immunol. 2018 Jan 15;200(2):450-458. doi: 10.4049/jimmunol.1701021. Review.

PMID:
29311387
2.

Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.

Mould RC, van Vloten JP, AuYeung AWK, Karimi K, Bridle BW.

Endocr Relat Cancer. 2017 Dec;24(12):T311-T329. doi: 10.1530/ERC-17-0316. Epub 2017 Sep 14. Review.

3.

Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.

Mould RC, AuYeung AWK, van Vloten JP, Susta L, Mutsaers AJ, Petrik JJ, Wood GA, Wootton SK, Karimi K, Bridle BW.

Sci Rep. 2017 Aug 16;7(1):8322. doi: 10.1038/s41598-017-08665-9.

4.

Truncation of the enzootic nasal tumor virus envelope protein cytoplasmic tail increases Env-mediated fusion and infectivity.

Walsh SR, de Jong JG, van Vloten JP, Gerpe MC, Santry LA, Wootton SK.

J Gen Virol. 2017 Jan;98(1):108-120. doi: 10.1099/jgv.0.000654. Epub 2017 Feb 6.

PMID:
27902399

Supplemental Content

Loading ...
Support Center